NVS - Novartis AG

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
210.37B
Enterprise Value 3
230.06B
Trailing P/E
18.26
Forward P/E 1
16.12
PEG Ratio (5 yr expected) 1
1.88
Price/Sales (ttm)
3.83
Price/Book (mrq)
3.99
Enterprise Value/Revenue 3
4.19
Enterprise Value/EBITDA 6
12.87

Trading Information

Stock Price History

Beta (3Y Monthly) 0.52
52-Week Change 317.81%
S&P500 52-Week Change 319.31%
52 Week High 395.00
52 Week Low 373.54
50-Day Moving Average 389.28
200-Day Moving Average 389.15

Share Statistics

Avg Vol (3 month) 31.71M
Avg Vol (10 day) 31.4M
Shares Outstanding 52.29B
Float 2.13B
% Held by Insiders 10.00%
% Held by Institutions 111.69%
Shares Short (Nov 15, 2019) 42.62M
Short Ratio (Nov 15, 2019) 41.84
Short % of Float (Nov 15, 2019) 4N/A
Short % of Shares Outstanding (Nov 15, 2019) 40.12%
Shares Short (prior month Oct 15, 2019) 43.31M

Dividends & Splits

Forward Annual Dividend Rate 42.83
Forward Annual Dividend Yield 43.08%
Trailing Annual Dividend Rate 32.89
Trailing Annual Dividend Yield 33.14%
5 Year Average Dividend Yield 43.28
Payout Ratio 493.54%
Dividend Date 3Mar 13, 2019
Ex-Dividend Date 4Mar 4, 2019
Last Split Factor (new per old) 21000/1116
Last Split Date 3Apr 9, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 21.49%
Operating Margin (ttm)23.11%

Management Effectiveness

Return on Assets (ttm)6.13%
Return on Equity (ttm)10.80%

Income Statement

Revenue (ttm)54.93B
Revenue Per Share (ttm)23.87
Quarterly Revenue Growth (yoy)9.60%
Gross Profit (ttm)36.08B
EBITDA 17.88B
Net Income Avi to Common (ttm)7.05B
Diluted EPS (ttm)5.07
Quarterly Earnings Growth (yoy)25.80%

Balance Sheet

Total Cash (mrq)8.63B
Total Cash Per Share (mrq)3.81
Total Debt (mrq)30.12B
Total Debt/Equity (mrq)57.26
Current Ratio (mrq)0.94
Book Value Per Share (mrq)23.19

Cash Flow Statement

Operating Cash Flow (ttm)13.85B
Levered Free Cash Flow (ttm)13.74B